Accepted for/Published in: JMIR Research Protocols
Date Submitted: May 18, 2021
Date Accepted: Jun 1, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Protocol for the Reducing Fear-Avoidance of Memory Loss (REFRAME) Study: A randomized controlled trial investigating the feasibility of a low-intensity psychological intervention for fear of memory loss and quality of life in older adults.
ABSTRACT
Background:
Dementia is the most feared disease associated with aging. These fears can have harmful consequences even in the absence of cognitive decline. Fear of dementia is associated with poorer health outcomes, reduced psychological wellbeing and increased memory failures in older adults.
Objective:
We will conduct a randomized controlled trial to determine the feasibility of a tailored, web-based mindfulness program to reduce fear of memory loss and increase quality of life in older adults experiencing heightened fear.
Methods:
One group will receive psychoeducation along with brief mindfulness training, which facilitates non-judgmental awareness to manage psychological distress. A second group will receive psychoeducation, mindfulness training and additional modules targeting maladaptive behavioral avoidance (i.e., social and cognitive withdrawal).
Results:
Our recent etiological model posits that maladaptive behavioral avoidance strategies critically underlie psycho-social dysfunction associated with fear of memory loss. Thus, we predict better outcomes in the second group, including fear of memory loss (primary outcome), fear of Alzheimer’s disease, quality of life, anxiety and subjective memory failures (secondary outcomes). Outcome measures will be applied at five time points (pre-, baseline, interim-, and post-intervention as well as at 3-month follow up).
Conclusions:
Data will be analyzed using mixed models, correlations and t-tests. This study was approved by the IRB at Northwestern University (USA) and data collection will take place between May and August 2021. Clinical Trial: Trial Registration Number: NCT04821960
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.